M 173 (Metolazone 5 mg)
Pill with imprint M 173 is Orange, Round and has been identified as Metolazone 5 mg. It is supplied by Mylan Pharmaceuticals Inc..
Metolazone is used in the treatment of edema; high blood pressure and belongs to the drug class thiazide diuretics. There is no proven risk in humans during pregnancy. Metolazone 5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M 173
Metolazone
- Imprint:
- M 173
- Strength:
- 5 mg
- Color:
- Orange
- Size:
- 6.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Thiazide diuretics
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Mylan Pharmaceuticals Inc.
- Inactive Ingredients:
- silicon dioxide
FD&C Yellow No. 6
magnesium stearate
microcrystalline cellulose
Note: Inactive ingredients may vary.
Other Labelers / Repackagers:
| NDC Code | Labeler / Repackager |
|---|---|
| 51079-0024 | UDL Laboratories Inc. |
More about metolazone
- Metolazone Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 4 Reviews
- Drug class: thiazide diuretics
Consumer resources
Other brands: Zaroxolyn, Mykrox
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
